ENDOTHELIN - POTENTIAL ROLE IN DEVELOPMENT AND DISEASE

被引：6

作者：

KON, V

FOGO, A

机构：

[1] Department of Pediatrics, Vanderbilt University School of Medicine, Nashville, 37232-2584, Tennessee

[2] Department of Pathology, Vanderbilt University School of Medicine, Nashville, 37232-2584, Tennessee

来源：

PEDIATRIC NEPHROLOGY | 1993年 / 7卷 / 06期

关键词：

ENDOTHELIN; VASOCONSTRICTION; DEVELOPMENT; GROWTH;

D O I：

10.1007/BF01213377

中图分类号：

R72 [儿科学];

学科分类号：

100202 ;

摘要：

Endothelin is a vasoconstrictor substance, initially isolated from porcine endothelial cell supernatant, which has a structure different from any other mammalian peptide. An extensive array of biological activities has been ascribed to endothelin which, besides having unrivaled vasoconstrictive effects, modulates neurotransmission, regulates other hormones and neurotransmitters, and also has potent hyperplastic/hypertrophic effects. These observations have suggested important roles for endothelin in pathophysiological conditions and also in normal development. Inhibition of endothelin activity can decrease vasoconstriction associated with pathophysiological settings. Inhibition of endothelin activity also decreases mitogenesis and therefore cellular proliferation and growth, thereby supporting a role for endothelin in processes which are an integral part of normal development.

引用

页码：876 / 880

页数：5

共 41 条

[21]

Simonson, Dunn M.J., Endothelin: pathways of transmembrane signaling, Hypertension, 15, pp. I5-I12, (1990)

[22]

Izumo S., Lompre A.M., Matsuoka R., Koren G., Schwartz K., Nadal-Ginard B., Mahdavi V., Myosin heavy chain messenger RNA and protein isoform transitions during cardiac hypertrophy, J Clin Invest, 79, pp. 970-977, (1987)

[23]

Wang C.Y., Daimon M., Shen S.J., Engelmann G.L., Ilan J., Insulin-like growth factor-I messenger ribonucleic acid in the developing human placenta and in term placenta of diabetics, Mol Endocrinol, 2, pp. 217-229, (1988)

[24]

Fant M.E., Munro H.N., Moses A.C., An autocrine/paracrine role for insulin-like growth factors (IGFs) in the regulation of human placental growth, J Clin Endocrinol Metab, 63, pp. 499-505, (1986)

[25]

Simonson, Dunn M.J., Endothelin peptides: a possible role in glomerular inflammation, Lab Invest, 64, pp. 1-4, (1991)

[26]

Zoja C., Orisio S., Perico N., Benigni A., Morigi M., Benatii L., Rambaldi A., Remuzzi G., Constitutive expression of endothelin gene in cultured human mesangial cells and its modulation by transforming growth factor β, thrombin, and a thromboxane A2 analogue, Lab Invest, 64, pp. 16-20, (1991)

[27]

Kon V., Sugiura M., Inagami T., Harvie B.R., Ichikawa I., Hoover R.L., Role of endothelin in cyclosporine-induced glomerular dysfunction, Kidney Int, 37, pp. 1487-1491, (1990)

[28]

Sugiura M., Inagami T., Kon V., Endotoxin stimulates endothelin-release in vivo and in vitro as determined by radioimmunoassay, Biochem Biophys Res Commun, 161, pp. 1220-1227, (1989)

[29]

Lerman A., Hildebrand F.L., Aarhus L.L., Burnett J.C.J., Endothelin has biological actions at pathophysiological concentrations, Circ Res, 83, pp. 1808-1814, (1991)

[30]

Heen A., Gillis C., Larsson O., Haegerstrand A., Lundberg J.M., Characterization, localization and actions of endothelins in umbilical vessels and placenta of man, Acta Physiol Scand, 143, pp. 395-404, (1991)

← 1 2 3 4 5 →